| PERIOD ENDING | 30-Sep-09 | 30-Sep-08 | 30-Sep-07 | | Total Revenue | 665,997 | 818,287 | 892,758 | | Cost of Revenue | 556,469 | 686,407 | 747,840 | | | Gross Profit | 109,528 | 131,880 | 144,918 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 108,328 | 117,366 | 137,638 | | Non Recurring | 7,407 | 4,701 | 765 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,742) | 9,813 | 6,515 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (711) | 2,767 | 336 | | Earnings Before Interest And Taxes | (6,918) | 12,580 | 6,851 | | Interest Expense | 4,526 | 8,623 | 5,835 | | Income Before Tax | (11,444) | 3,957 | 1,016 | | Income Tax Expense | 495 | 2,921 | 2,041 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,939) | 1,036 | (1,025) | | | Non-recurring Events | | Discontinued Operations | 119 | (352) | (3,387) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,820) | 684 | (4,412) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,820) | $684 | ($4,412) |
|
0.10% Nasdaq 
0.34%
Income Statement
